Find Bromelain manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Muxf, M0xf(3), Bromelain, technical grade, Chebi:53469, 9001-00-7, Fuc-alpha-(1->3)-[man-alpha-(1->6)-[xyl-beta-(1->2)]-man-beta-(1->4)-glcnac-beta-(1->4)]-glcnac
Molecular Formula
C39H66N2O29
Molecular Weight
1026.9  g/mol
InChI Key
UNMLVGNWZDHBRA-UFAVQCRNSA-N

Bromelain
Protein-digesting and milk-clotting enzymes found in PINEAPPLE fruit juice and stem tissue. Enzymes from the two sources are distinguished as fruit bromelain and stem bromelain. This enzyme was formerly listed as EC 3.4.22.4.
1 2D Structure

Bromelain

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5R)-5-acetamido-6-hydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-5-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
2.1.2 InChI
InChI=1S/C39H66N2O29/c1-9-19(48)24(53)29(58)38(62-9)69-32-18(41-11(3)46)34(59)63-15(6-44)31(32)68-35-17(40-10(2)45)23(52)30(14(5-43)65-35)67-39-33(70-37-27(56)20(49)12(47)7-60-37)26(55)22(51)16(66-39)8-61-36-28(57)25(54)21(50)13(4-42)64-36/h9,12-39,42-44,47-59H,4-8H2,1-3H3,(H,40,45)(H,41,46)/t9-,12+,13+,14+,15+,16+,17+,18+,19+,20-,21+,22+,23+,24+,25-,26-,27+,28-,29-,30+,31+,32+,33-,34?,35-,36-,37-,38-,39-/m0/s1
2.1.3 InChI Key
UNMLVGNWZDHBRA-UFAVQCRNSA-N
2.1.4 Canonical SMILES
CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)COC5C(C(C(C(O5)CO)O)O)O)O)O)OC6C(C(C(CO6)O)O)O)O)NC(=O)C)CO)O)NC(=O)C)O)O)O
2.1.5 Isomeric SMILES
C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2[C@@H]([C@H](OC([C@@H]2NC(=O)C)O)CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO[C@@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)O)NC(=O)C)O)O)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Ananase

2. Bromelain

3. Bromelain Pos

4. Bromelain-pos

5. Bromelainpos

6. Bromelains

7. Bromelin

8. Bromelins

9. Dayto Anase

10. Debrase

11. Dontisanin

12. Extranase

13. Mucozym

14. Proteozym

15. Traumanase

2.2.2 Depositor-Supplied Synonyms

1. Muxf

2. M0xf(3)

3. Bromelain, Technical Grade

4. Chebi:53469

5. 9001-00-7

6. Fuc-alpha-(1->3)-[man-alpha-(1->6)-[xyl-beta-(1->2)]-man-beta-(1->4)-glcnac-beta-(1->4)]-glcnac

7. Alpha-l-fuc-(1->3)-[alpha-d-man-(1->6)-[beta-d-xyl-(1->2)]-beta-d-man-(1->4)-beta-d-glcnac-(1->4)]-d-glcnac

8. Alpha-l-fucopyranosyl-(1->3)-[alpha-d-mannopyranosyl-(1->6)-[beta-d-xylopyranosyl-(1->2)]-beta-d-mannopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-d-glucopyranosyl-(1->4)]-2-acetamido-2-deoxy-d-glucopyranose

9. Alpha-l-fucosyl-(1->3)-[alpha-d-mannosyl-(1->6)-[beta-d-xylosyl-(1->2)]-beta-d-mannosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->4)]-n-acetyl-d-glucosamine

10. Alpha-l-fucp-(1->3)-[alpha-d-manp-(1->6)-[beta-d-xylp-(1->2)]-beta-d-manp-(1->4)-beta-d-glcpnac-(1->4)]-d-glcpnac

11. Bromelaine

12. Epitope Id:115005

13. Q27124066

14. N_full_22100100000000_gs_1023_c1

15. Man(a1-6)[xyl(b1-2)]man(b1-4)glcnac(b1-4)[fuc(a1-3)]glcnac

16. Wurcs=2.0/6,6,5/[a2122h-1x_1-5_2*ncc/3=o][a1221m-1a_1-5][a2122h-1b_1-5_2*ncc/3=o][a1122h-1b_1-5][a212h-1b_1-5][a1122h-1a_1-5]/1-2-3-4-5-6/a3-b1_a4-c1_c4-d1_d2-e1_d6-f1

2.3 Create Date
2009-11-19
3 Chemical and Physical Properties
Molecular Weight 1026.9 g/mol
Molecular Formula C39H66N2O29
XLogP3-11.6
Hydrogen Bond Donor Count18
Hydrogen Bond Acceptor Count29
Rotatable Bond Count16
Exact Mass1026.37512407 g/mol
Monoisotopic Mass1026.37512407 g/mol
Topological Polar Surface Area483 Ų
Heavy Atom Count70
Formal Charge0
Complexity1680
Isotope Atom Count0
Defined Atom Stereocenter Count28
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Bromelain has /shown/ some success as a substitute for trypsin and pepsin in cases of pancreatic insufficiency and post-pancreatectomy.

Medical Economics Co; Physicians Desk Reference for Nutritional Supplements 1st ed p.72 (2001)


Acute postoperative and post-traumatic conditions of swelling, especially of the nasal and paranasal sinuses.

Blumenthal M, ed; The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines p.94 (1998)


In an open case observation study involving patients with blunt injuries to the musculoskeletal system, the efficacy and tolerability of high-dose Bromelain POS, a plant-derived enzyme preparation, were investigated. The investigating physician was an orthopedic surgeon who, in addition to the usual therapeutic measures, treated 59 of his patients with the bromelaine preparation. The duration of the application was determined by the nature and severity of the lesion, and varied between one and three weeks. The test criteria were swelling, pain at rest and during movement, and tenderness. These parameters were evaluated on the day of the injury and on five subsequent dates. Treatment with bromelaine resulted in a clear reduction in all four parameters tested. Both swelling and the symptoms of pain had improved appreciably at all evaluation time points as compared with baseline. The tolerability of the preparation was very good, and patient compliance was correspondingly high.

PMID:7672747 Masson M; Fortschr Med 113 (19): 303-6 (1995)


4.2 Drug Warning

Gastrointestinal symptoms such as nausea and vomiting, diarrhea and cramping have been reported. There are occasional reports of metrorrhagia and menorrhagia.

Medical Economics Co; Physicians Desk Reference for Nutritional Supplements 1st ed p.72 (2001)


As with papain and other proteases, bromelain may cause contact allergenic reactions in certain individuals.

Leung, A.Y., Foster, S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, NY. John Wiley & Sons, Inc. 1996., p. 101


Bromelain supplements should be avoided by pregnant women and nursing mothers.

Medical Economics Co; Physicians Desk Reference for Nutritional Supplements 1st ed p.70 (2001)


In one double-blind study of 73 patients with acute thrombophlebitis, bromelain, used with analgesics, reduced pain, edema, redness, tenderness, elevated skin temperature and disability.

Medical Economics Co; Physicians Desk Reference for Nutritional Supplements 1st ed p.72 (2001)


Those on anticoagulants or antithrombotic agents should exercise caution in the use of bromelain. Bromelain may have blood thinning activity in some.

Medical Economics Co; Physicians Desk Reference for Nutritional Supplements 1st ed p.70 (2001)


5 Pharmacology and Biochemistry
5.1 Absorption, Distribution and Excretion

Evidence that bromelains (I) is absorbed from the gastrointestinal tract of rats after oral administration is demonstrated in a bioavailability study in which 125I is given by oral route to rats and blood levels sampled at various times thereafter. A maximum level of 270 ng/ml I was found at one hr after administration.

PMID:3207859 White RR et al; Biopharm Drug Dispos 9 (Jul-Aug): 397-403 (1988)


Bromelain, a standardized complex of proteases from the pineapple plant, is absorbed unchanged from the intestine of animals at a rate of 40% ... .

PMID:2203073 Lotz-Winter H; Planta Med 56 (3): 249-53 (1990)


5.2 Mechanism of Action

It has been postulated that a minor enzymatic component present in bromelain is responsible for the release of a kinin, which stimulates the production of prostaglandin E1-like compounds; These PGE1-like compounds are then responsible for the physiological activities of bromelain.

Leung, A.Y., Foster, S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, NY. John Wiley & Sons, Inc. 1996., p. 101


Bromelain's digestant activity is based on its ability to hydrolyze proteins to oligopeptides and amino acids. Bromelain's proteolytic enzymes are cysteine proteases. Cysteine proteases cleave peptide bonds by nucleophilic attack via active-site cysteine residues.

Medical Economics Co; Physicians Desk Reference for Nutritional Supplements 1st ed p.71 (2001)


The mechanism of the putative anti-inflammatory activity ... may be accounted for, in part, by activation of plasmin production from plasminogen and reduction of kinin via inhibition of the conversion of kininogen to kinin. Other possibilities, may include proteolytic degradation of circulating immune complexes and inhibition of signaling by extracellular regulated kinase (ERK-2) and p21 ras.

Medical Economics Co; Physicians Desk Reference for Nutritional Supplements 1st ed p.71 (2001)


Bromelain has been shown to increase CD2-mediated T cell activation, to enhance antigen-independent binding to monocytes and to increase interferon (IFN)-gamma-dependant, tumor necrosis factor (TNF)-alpha, Interleukin (IL)-1 beta, and interleukin (IL)-6 production in peripheral blood monocytes. These effects are thought to be due to bromelains proteolytic activity at cell surfaces, whereby it either removes surface molecules or reveals ones that already exist on cell membranes, thereby altering receptor-ligand interactions.

Medical Economics Co; Physicians Desk Reference for Nutritional Supplements 1st ed p.71 (2001)


For more Mechanism of Action (Complete) data for BROMELAINS (7 total), please visit the HSDB record page.


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630348200,"product":"BROMELAIN (2500GDUG)","address":"501, SAMEDH BUILDING,NR. ASSOCIATEDPETROL PUMP, C.G. ROAD, NAVRANGPURA","city":"AHMEDABAD","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BONANZA","customer":"ACTIVE PHARMA","customerCountry":"UNITED STATES","quantity":"300.00","actualQuantity":"300","unit":"KGS","unitRateFc":"23","totalValueFC":"6849.4","currency":"USD","unitRateINR":1693.3333333333333,"date":"31-Aug-2021","totalValueINR":"508000","totalValueInUsd":"6849.4","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"4263582","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"501, SAMEDH BUILDING,NR. ASSOCIATEDPETROL PUMP, C.G. ROAD, NAVRANGPURA, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1634581800,"product":"BROMELAIN","address":"501, SAMEDH BUILDING,NR. ASSOCIATEDPETROL PUMP, C.G. ROAD, NAVRANGPURA","city":"AHMEDABAD","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BUSAN(KOREA)","customer":"SJD","customerCountry":"KOREA, REPUBLIC OF","quantity":"200.00","actualQuantity":"200","unit":"KGS","unitRateFc":"50","totalValueFC":"9878.3","currency":"USD","unitRateINR":3700,"date":"19-Oct-2021","totalValueINR":"740000","totalValueInUsd":"9878.3","indian_port":"JNPT","hs_no":"29146990","bill_no":"5393717","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"JNPT","supplierAddress":"501, SAMEDH BUILDING,NR. ASSOCIATEDPETROL PUMP, C.G. ROAD, NAVRANGPURA, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1634754600,"product":"BROMELAIN","address":"501, SAMEDH BUILDING,NR. ASSOCIATEDPETROL PUMP, C.G. ROAD, NAVRANGPURA","city":"AHMEDABAD","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TRANSOL ARISAN KIMYA SANAYI VE DEPO","customerCountry":"TURKEY","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"58","totalValueFC":"53.4","currency":"USD","unitRateINR":4000,"date":"21-Oct-2021","totalValueINR":"4000","totalValueInUsd":"53.4","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"5456182","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"501, SAMEDH BUILDING,NR. ASSOCIATEDPETROL PUMP, C.G. ROAD, NAVRANGPURA, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1636914600,"product":"BROMELAIN 2500 GDU\/G","address":"501, SAMEDH BUILDING,NR. ASSOCIATEDPETROL PUMP, C.G. ROAD, NAVRANGPURA","city":"AHMEDABAD","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"PT HOPE","customer":"ACTIVE PHARMA","customerCountry":"BRAZIL","quantity":"350.00","actualQuantity":"350","unit":"KGS","unitRateFc":"23","totalValueFC":"7989.7","currency":"USD","unitRateINR":1700,"date":"15-Nov-2021","totalValueINR":"595000","totalValueInUsd":"7989.7","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"6015155","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"501, SAMEDH BUILDING,NR. ASSOCIATEDPETROL PUMP, C.G. ROAD, NAVRANGPURA, AHMEDABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639938600,"product":"BROMELAIN ASSAY MIN. 2500 GDU","address":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR","city":"AHMEDABAD,GUJARAT","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SALT LAKE, UT","customer":"KNV CHEMICALS INC","customerCountry":"UNITED STATES","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"36","totalValueFC":"13509.9","currency":"USD","unitRateINR":2038,"date":"20-Dec-2021","totalValueINR":"1019000","totalValueInUsd":"13509.9","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"6881292","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639938600,"product":"BROMELAIN ASSAY MIN. 2500 GDU","address":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR","city":"AHMEDABAD,GUJARAT","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SALT LAKE, UT","customer":"KNV CHEMICALS INC","customerCountry":"UNITED STATES","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"36","totalValueFC":"13509.9","currency":"USD","unitRateINR":2038,"date":"20-Dec-2021","totalValueINR":"1019000","totalValueInUsd":"13509.9","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"6881401","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639938600,"product":"BROMELAIN ASSAY MIN. 2500 GDU","address":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR","city":"AHMEDABAD,GUJARAT","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SALT LAKE, UT","customer":"KNV CHEMICALS INC","customerCountry":"UNITED STATES","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"36","totalValueFC":"13509.9","currency":"USD","unitRateINR":2038,"date":"20-Dec-2021","totalValueINR":"1019000","totalValueInUsd":"13509.9","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"6881412","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639938600,"product":"BROMELAIN ASSAY MIN. 2500 GDU","address":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR","city":"AHMEDABAD,GUJARAT","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SALT LAKE, UT","customer":"KNV CHEMICALS INC","customerCountry":"UNITED STATES","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"36","totalValueFC":"13509.9","currency":"USD","unitRateINR":2038,"date":"20-Dec-2021","totalValueINR":"1019000","totalValueInUsd":"13509.9","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"6881546","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640025000,"product":"BROMELAIN ASSAY MIN. 2500 GDU","address":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR","city":"AHMEDABAD,GUJARAT","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SALT LAKE, UT","customer":"3)MISHKA GROUPLLC U,S,A","customerCountry":"UNITED STATES","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"36","totalValueFC":"13509.9","currency":"USD","unitRateINR":2038,"date":"21-Dec-2021","totalValueINR":"1019000","totalValueInUsd":"13509.9","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"6916262","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640025000,"product":"BROMELAIN ASSAY MIN. 2500 GDU","address":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR","city":"AHMEDABAD,GUJARAT","supplier":"METEORIC BIOPHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"SALT LAKE, UT","customer":"KNV CHEMICALS INC","customerCountry":"UNITED STATES","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"36","totalValueFC":"13509.9","currency":"USD","unitRateINR":2038,"date":"21-Dec-2021","totalValueINR":"1019000","totalValueInUsd":"13509.9","indian_port":"BOMBAY AIR","hs_no":"29146990","bill_no":"6916277","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"204,205,206 SHIROMANI COMPLEX,NEHR UNAGAR, AHMEDABAD,GUJARAT","customerAddress":""}]
31-Aug-2021
21-Dec-2021
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

MW005, our topical enzymatic therapy for the treatment of non-melanoma skin cancers received positive initial data from the Company’s U.S. Phase I/II study of MW005 for the treatment of low-risk basal cell carcinoma (BCC).


Lead Product(s): Bromelain

Therapeutic Area: Oncology Brand Name: MW005

Study Phase: Phase I/ Phase IIProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 10, 2023

blank

01

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Details : MW005, our topical enzymatic therapy for the treatment of non-melanoma skin cancers received positive initial data from the Company’s U.S. Phase I/II study of MW005 for the treatment of low-risk basal cell carcinoma (BCC).

Brand Name : MW005

Molecule Type : Large molecule

Upfront Cash : Not Applicable

July 10, 2023

blank

Details:

The Company intends to use the net proceeds from the offering primarily for the acceleration of the development of EscharEx® (bromelain), establishing a U.S. commercial presence, supporting business development activities, and for general corporate purposes.


Lead Product(s): Bromelain

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: EscharXR

Study Phase: Phase IIProduct Type: Large molecule

Sponsor: H.C. Wainwright & Co.

Deal Size: $27.5 million Upfront Cash: Undisclosed

Deal Type: Public Offering February 07, 2023

blank

02

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Details : The Company intends to use the net proceeds from the offering primarily for the acceleration of the development of EscharEx® (bromelain), establishing a U.S. commercial presence, supporting business development activities, and for general corporate purp...

Brand Name : EscharXR

Molecule Type : Large molecule

Upfront Cash : Undisclosed

February 07, 2023

blank

Details:

The Company intends to use the net proceeds from the offering primarily for the acceleration of the development of EscharEx. EscharEx, a concentrate of proteolytic enzymes enriched in bromelain, is an easy to use product candidate, for topical daily applications.


Lead Product(s): Bromelain

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: EscharXR

Study Phase: Phase IIProduct Type: Large molecule

Sponsor: H.C. Wainwright & Co.

Deal Size: $27.5 million Upfront Cash: Undisclosed

Deal Type: Public Offering February 03, 2023

blank

03

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Details : The Company intends to use the net proceeds from the offering primarily for the acceleration of the development of EscharEx. EscharEx, a concentrate of proteolytic enzymes enriched in bromelain, is an easy to use product candidate, for topical daily appl...

Brand Name : EscharXR

Molecule Type : Large molecule

Upfront Cash : Undisclosed

February 03, 2023

blank

Details:

Through the acquisition, Sun Pharma strengthen its anti-inflammatory portfolio by adding Disperzyme (bromelain), Disperzyme-CD and Phlogam from Aksigen Hospital Care.


Lead Product(s): Bromelain,Trypsin,Rutin

Therapeutic Area: Neurology Brand Name: Disperzyme

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Sun Pharmaceutical Industries Limited

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition January 30, 2023

blank

04

Luxepack
Not Confirmed
Luxepack
Not Confirmed

Details : Through the acquisition, Sun Pharma strengthen its anti-inflammatory portfolio by adding Disperzyme (bromelain), Disperzyme-CD and Phlogam from Aksigen Hospital Care.

Brand Name : Disperzyme

Molecule Type : Small molecule

Upfront Cash : Undisclosed

January 30, 2023

blank

Details:

NexoBrid® (concentrate of proteolytic enzymes enriched in bromelain) is a topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns within four hours.


Lead Product(s): Bromelain

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: NexoBrid

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable December 13, 2022

blank

05

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Details : NexoBrid® (concentrate of proteolytic enzymes enriched in bromelain) is a topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns within four h...

Brand Name : NexoBrid

Molecule Type : Large molecule

Upfront Cash : Not Applicable

December 13, 2022

blank

Details:

NexoBrid (bromelain) is a topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns within four hours of application without harming viable tissue.


Lead Product(s): Bromelain

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: NexoBrid

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 03, 2022

blank

06

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Details : NexoBrid (bromelain) is a topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns within four hours of application without harming viable tissue...

Brand Name : NexoBrid

Molecule Type : Large molecule

Upfront Cash : Not Applicable

August 03, 2022

blank

Details:

BARDA is providing funds to develop NexoBrid & support NexoBrid’s potential approval to enhance U.S preparedness. NexoBrid, product for non-surgical eschar removal & full-thickness thermal burns, is a bromelain-based product containing a sterile mixture of proteolytic enzymes.


Lead Product(s): Bromelain

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: NexoBrid

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Biomedical Advanced Research and Development Authority

Deal Size: $211.0 million Upfront Cash: Undisclosed

Deal Type: Funding February 10, 2022

blank

07

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Lead Product(s) : Bromelain

Therapeutic Area : Trauma (Emergency, Injury, Surgery)

Highest Development Status : Approved

Partner/Sponsor/Collaborator : Biomedical Advanced Research and Development Authority

Deal Size : $211.0 million

Deal Type : Funding

Details : BARDA is providing funds to develop NexoBrid & support NexoBrid’s potential approval to enhance U.S preparedness. NexoBrid, product for non-surgical eschar removal & full-thickness thermal burns, is a bromelain-based product containing a sterile mixtur...

Brand Name : NexoBrid

Molecule Type : Large molecule

Upfront Cash : Undisclosed

February 10, 2022

blank

Details:

The phase II investigator-initiated trial is an open-label study, designed to evaluate the safety and efficacy of MW005 in removing non-melanoma skin cancers and pre-cancerous lesions (e.g., actinic keratosis, BCC, and squamous cell carcinoma) in up to 50 patients.


Lead Product(s): Bromelain

Therapeutic Area: Oncology Brand Name: MW005

Study Phase: PreclinicalProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 26, 2021

blank

08

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Details : The phase II investigator-initiated trial is an open-label study, designed to evaluate the safety and efficacy of MW005 in removing non-melanoma skin cancers and pre-cancerous lesions (e.g., actinic keratosis, BCC, and squamous cell carcinoma) in up to 5...

Brand Name : MW005

Molecule Type : Large molecule

Upfront Cash : Not Applicable

July 26, 2021

blank

Details:

NexoBrid (concentrate of proteolytic enzymes enriched in Bromelain) is a topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns within four hours of application.


Lead Product(s): Bromelain

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: NexoBrid

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 29, 2021

blank

09

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Details : NexoBrid (concentrate of proteolytic enzymes enriched in Bromelain) is a topically administered biological product that enzymatically removes nonviable burn tissue, or eschar, in patients with deep partial and full-thickness thermal burns within four hou...

Brand Name : NexoBrid

Molecule Type : Large molecule

Upfront Cash : Not Applicable

June 29, 2021

blank

Details:

MediWound has entered the Middle Eastern markets with the signing of a distribution agreement granting Ghassan Aboud Group, an exclusive right to market and distribute NexoBrid in UAE for the treatment of severe burns.


Lead Product(s): Bromelain

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: NexoBrid

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Ghassan Aboud Group

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership December 14, 2020

blank

10

MediWound

Israel
arrow
Luxepack
Not Confirmed

MediWound

Israel
arrow
Luxepack
Not Confirmed

Details : MediWound has entered the Middle Eastern markets with the signing of a distribution agreement granting Ghassan Aboud Group, an exclusive right to market and distribute NexoBrid in UAE for the treatment of severe burns.

Brand Name : NexoBrid

Molecule Type : Large molecule

Upfront Cash : Undisclosed

December 14, 2020

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty